Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$94.60 +0.18 (+0.19%)
As of: Nov 11, 2026 · 11:57 AM EST

Mirum Pharmaceuticals (MIRM) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Mirum Pharmaceuticals' Depreciation & Amortization (CF) came in at $6.89 million for Q3 2026, up 13.6% from $6.06 million a year earlier but down 0.7% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Mirum Pharmaceuticals reported Depreciation & Amortization (CF) of $26.77 million, up 10.5% year-over-year; for FY2025, it came in at $24.24 million, up 2.6% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last six years, with a five-year compound annual growth rate of 139.9% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $23.63 million in FY2024 (+118.2%), $10.83 million in FY2023 (+234.4%), $3.24 million in FY2022 (+444.2%) and $595,000 in FY2021 (+95.1%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $342,000 (Q4 2021) to $6.94 million (Q2 2026).
  • Year-over-year, Depreciation & Amortization (CF) has increased for 16 consecutive quarters, with growth averaging 7.8% over the last eight quarters.
  • The year-over-year growth in Depreciation & Amortization (CF) has ranged between 0.1% (Q3 2025) and 658.2% (Q2 2022) over the last five years.
  • Business Quant data shows MIRM's Depreciation & Amortization (CF) at $6.94 million (Q2 2026), $6.87 million (Q1 2026) and $6.07 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Mirum Pharmaceuticals 6.16 Bn 4.58 Bn 150.55 Mn 6.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.89 Mn
Jun 30, 2026 6.94 Mn
Mar 31, 2026 6.87 Mn
Dec 31, 2025 6.07 Mn
Sep 30, 2025 6.06 Mn
Jun 30, 2025 6.06 Mn
Mar 31, 2025 6.05 Mn
Dec 31, 2024 6.06 Mn
Sep 30, 2024 6.06 Mn
Jun 30, 2024 5.85 Mn
Mar 31, 2024 5.66 Mn
Dec 31, 2023 5.49 Mn
Sep 30, 2023 2.66 Mn
Jun 30, 2023 1.34 Mn
Mar 31, 2023 1.34 Mn
Dec 31, 2022 1.20 Mn
Sep 30, 2022 1.10 Mn
Jun 30, 2022 599,000.00
Mar 31, 2022 342,000.00
Dec 31, 2021 342,000.00
API Access

Mirum Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MIRM&period=max&api_key=YOUR_API_KEY